Hyalinizing clear cell carcinoma of salivary glands: An integrative review of clinical, pathological, and molecular features - 21/11/26
, Lorrayne Naysla de Paula a, Letícia Alves Pereira Kirchimair a, Lara Rezende Rena Rodrigues a, Priscila Faquini Macedo Neto b, Fabrício Tinôco Alvim de Souza aAbstract |
Hyalinizing clear cell carcinoma (HCCC) is a rare malignant neoplasm of the salivary glands characterized by distinctive histopathological and molecular features and generally indolent behavior. This integrative literature review aimed to synthesize current evidence regarding the clinical presentation, histopathological characteristics, immunohistochemical profile, molecular alterations, treatment, and prognostic factors associated with oral HCCC. A literature search was conducted in PubMed, LILACS, and Scopus, including studies published between January 2005 and December 2025. After removal of duplicates and application of eligibility criteria, 24 studies were included. The evidence comprised case reports, case series, retrospective studies, molecular investigations, laboratory studies, and multicenter analyses. HCCC demonstrated a female predominance and preferential involvement of minor salivary glands, particularly the palate and tongue. Clinically, lesions commonly presented as painless, slow-growing submucosal nodules with prolonged evolution. Histologically, HCCC was characterized by polygonal cells with clear to slightly eosinophilic cytoplasm arranged in nests, cords, and trabeculae within a hyalinized stromal background. Immunohistochemically, tumor cells typically expressed epithelial and basal markers, including AE1/AE3, cytokeratin 7, p63, and p40, while lacking S100 and smooth muscle actin expression, supporting differentiation from other clear cell neoplasms. The EWSR1::ATF1 fusion was the most frequent molecular alteration, although EWSR1::CREM and EWSR1::LARP4 fusions have expanded the molecular spectrum. Wide local excision with adequate margins remains the main treatment, while radiotherapy is reserved for selected high-risk cases. Although HCCC generally has favorable outcomes, aggressive subgroups may develop high-grade transformation, recurrence, and metastasis, emphasizing the importance of long-term surveillance.
Le texte complet de cet article est disponible en PDF.Keywords : Hyalinizing clear cell carcinoma, Salivary gland neoplasms, Minor salivary glands, EWSR1-ATF1 fusion, Oral cavity, Immunohistochemistry
Plan
Vol 127 - N° 6
Article 103073- décembre 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
